The NHS has today published its Long Term Plan setting out what it will be prioritising in the future.
The UK and the EU have agreed on a post-Brexit trade deal.
Several countries have closed their borders to the UK, including France.
The ABPI Board is pleased to announce that Kate Brunner QC has been appointed Chair of the PMCPA Appeal Board.
The government has announced a new £20 million Medicines and Diagnostic Manufacturing Transformation Fund to expand medicines manufacturing and improve medicine supply chains.
The Chancellor has unveiled the government's spending plans for the coming year, including for NHS funding, clinical research, and cutting-edge R&D.
Following the fourth meeting of the Ireland/Northern Ireland Specialised Committee, the UK and the EU have agreed a phased process for implementing medicines regulation in Northern Ireland up to 31 December 2021.
The growing importance of Northern Ireland’s pharmaceutical and life sciences industries is revealed in a new report tracking the significant contribution the sector makes to the NI economy.
The Prime Minister has said that the UK must prepare for 'no deal' but has indicated that negotiations between the EU and UK on the post-Brexit relationship will continue.
The UK is set to join two initiatives bringing together some of the world’s leading regulators to allow pharmaceutical companies to submit medicines to be reviewed by several countries at the same time.